Timber Pharmaceuticals Buy Hold or Sell Recommendation

TMBRDelisted Stock  USD 1.72  0.01  0.58%   
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Timber Pharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Timber Pharmaceuticals given historical horizon and risk tolerance towards Timber Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Timber Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note, we conduct extensive research on individual companies such as Timber and provide practical buy, sell, or hold advice based on investors' constraints. Timber Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute Timber Pharmaceuticals Buy or Sell Advice

The Timber recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Timber Pharmaceuticals. Macroaxis does not own or have any residual interests in Timber Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Timber Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Timber PharmaceuticalsBuy Timber Pharmaceuticals
Not Rated
For the selected time horizon Timber Pharmaceuticals has a Risk Adjusted Performance of 0.0555, Jensen Alpha of 0.2661, Total Risk Alpha of (0.61), Sortino Ratio of 0.0441 and Treynor Ratio of 0.4359
We provide advice to complement the current expert consensus on Timber Pharmaceuticals. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Timber Pharmaceuticals is not overpriced, please validate all Timber Pharmaceuticals fundamentals, including its debt to equity, and the relationship between the ebitda and earnings per share . Please also confirm Timber Pharmaceuticals price to book to double-check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Timber Pharmaceuticals Trading Alerts and Improvement Suggestions

Timber Pharmaceuticals is not yet fully synchronised with the market data
Timber Pharmaceuticals may become a speculative penny stock
Timber Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 83.18 K. Net Loss for the year was (19.38 M) with loss before overhead, payroll, taxes, and interest of (5.26 M).
Timber Pharmaceuticals currently holds about 11.22 M in cash with (15.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Timber Pharmaceuticals Returns Distribution Density

The distribution of Timber Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Timber Pharmaceuticals' future price movements. The chart of the probability distribution of Timber Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Timber Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Timber Pharmaceuticals returns is essential to provide solid investment advice for Timber Pharmaceuticals.
Mean Return
0.38
Value At Risk
-7.77
Potential Upside
13.02
Standard Deviation
6.21
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Timber Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Pirozzi Gianluca of 4100 shares of Timber Pharmaceuticals subject to Rule 16b-3 [view details]

Timber Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Timber . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Timber Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Timber Pharmaceuticals? Buying financial instruments such as Timber Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Timber Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Timber Stock

If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stocks Directory
Find actively traded stocks across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data